September 26, 2018 — Patients with heart failure and secondary mitral regurgitation (MR) who remained symptomatic ...
Diagnostic and Interventional Cardiology DAIC
Diagnostic and Interventional Cardiology (DAIC) is a magazine that reaches more than 25,000 healthcare professionals in cardiology, interventional cardiology and cath labs across the United States. These influential buying team members rely on DAIC's award-winning editorial content and comparison charts as a unique research tool for specifying, recommending and approving technology/device purchases.
September 25, 2018 — Five-month-old Jack Palmer is home with his family in Kansas City after undergoing an extremely ...
September 24, 2018 — Ancora Heart Inc. announced positive clinical data from the company’s recently expanded U.S. early ...
September 24, 2018 — Getinge is voluntarily initiating a worldwide recall involving a field correction of approximately ...
October 4, 2018 – The Cardiovascular Research Foundation (CRF) had 15 late-breaking trials and 12 late-breaking clinical ...
September 20, 2018 — Cardiac Dimensions announced the company has randomized its first patient in the CARILLON Pivotal ...
September 19, 2018 — Abiomed Inc. announces its initiatives at the 30th Transcatheter Cardiovascular Therapeutics (TCT) ...
September 19, 2018 – The U.S. Food and Drug Administration (FDA) has approved an investigational device exemption (IDE) ...
William O’Neill, M.D., outlines his recent clinical publication of AMICS patients from the Impella Quality (IQ) database ...
September 17, 2018 — 4C Medical Technologies Inc. announced that its AltaValve transcatheter mitral valve replacement ...
The volume of information attendees receive at the annual Transcatheter Cardiovascular Therapeutics (TCT) interventional ...
Coronary artery disease (CAD) is a multifaceted disease that demands various approaches in terms of diagnosis and ...
September 7, 2018 — The antithrombin drug rivaroxaban does not reduce the risk of a composite endpoint of survival ...
September 6, 2018 — Tafamidis is the first treatment to improve survival and reduce hospitalizations in a rare heart ...
September 6, 2018 – W. L. Gore & Associates Inc. (Gore) announced the acquisition of Pipeline Medical Technologies Inc ...